Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

被引：0
|
作者：
Rikke Hebo Larsen
Lisa Lyngsie Hjalgrim
Kathrine Grell
Kim Kristensen
Line Gerner Pedersen
Emilie Damgaard Brünner
Bodil Als-Nielsen
Kjeld Schmiegelow
Jacob Nersting
机构：
[1] University Hospital Rigshospitalet,Department of Pediatrics and Adolescent Medicine
[2] University of Copenhagen,Section of Biostatistics, Department of Public Health
[3] Novo Nordisk,Discovery and Development PKPD
[4] University of Copenhagen,Institute of Clinical Medicine, Faculty of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Childhood acute lymphoblastic leukemia; Leukemia; Cancer; Mercaptopurine; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 32
页数：7
相关论文
共 50 条
  • [31] IS 6-THIOGUANINE MORE APPROPRIATE THAN 6-MERCAPTOPURINE FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    LENNARD, L
    DAVIES, HA
    LILLEYMAN, JS
    BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 186 - 190
  • [32] Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia
    Relling, MV
    Hancock, ML
    Boyett, JM
    Pui, CH
    Evans, WE
    BLOOD, 1999, 93 (09) : 2817 - 2823
  • [33] PHARMACOKINETIC DETERMINANTS OF 6-MERCAPTOPURINE MYELOTOXICITY AND THERAPEUTIC FAILURE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    SULH, H
    KOREN, G
    WHALEN, C
    SOLDIN, S
    ZIPURSKY, A
    GREENBERG, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (06) : 604 - 609
  • [34] ORAL MANIFESTATIONS OF ACUTE MONOCYTIC LEUKEMIA TREATED WITH 6-MERCAPTOPURINE
    DIEHL, DL
    PERIODONTICS, 1967, 5 (03): : 142 - &
  • [35] DIURNAL-VARIATION IN 6-MERCAPTOPURINE PHARMACOKINETICS AND MYELOTOXICITY IN CHILDREN WITH LEUKEMIA
    KOREN, G
    LANGEVIN, AM
    OLIVIERI, N
    GIESBRECHT, E
    ZIPURSKY, A
    GREENBERG, M
    PEDIATRIC RESEARCH, 1989, 25 (04) : A69 - A69
  • [36] Maintenance chemotherapy of acute lymphoblastic leukemia in children - Clinical and pharmacological aspects of the monitoring and adjustment of oral methotrexate and 6-mercaptopurine dosage
    Schmiegelow, K
    DANISH MEDICAL BULLETIN, 1998, 45 (05) : 510 - 532
  • [37] 6-MERCAPTOPURINE INDUCED SYMPTOMATIC HYPOGLYCAEMIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA
    White, M.
    Storey, L.
    Costigan, C.
    Smith, O.
    PEDIATRIC RESEARCH, 2010, 68 : 551 - 552
  • [38] Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia
    Zhou, Yue
    Wang, Li
    Zhai, Xiao-Ying
    Wen, Li
    Tang, Fang
    Yang, Fan
    Liu, Xi-Ting
    Dong, Lei
    Zhi, Li-Juan
    Shi, Hai-Yan
    Hao, Guo-Xiang
    Zheng, Yi
    Jacqz-Aigrain, Evelyne
    Wang, Tian-You
    Zhao, Wei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (08) : 1519 - 1527
  • [39] COMPARISON OF 6-MERCAPTOPURINE WITH THE COMBINATION OF 6-MERCAPTOPURINE AND AZASERINE IN THE TREATMENT OF ACUTE LEUKEMIA IN CHILDREN - RESULTS OF A COOPERATIVE STUDY
    HEYN, RM
    BRUBAKER, CA
    BURCHENAL, JH
    CRAMBLETT, HG
    WOLFF, JA
    BLOOD, 1960, 15 (03) : 350 - 359
  • [40] IMPORTANCE OF 6-MERCAPTOPURINE DOSE IN LYMPHOBLASTIC-LEUKEMIA
    HALE, JP
    LILLEYMAN, JS
    ARCHIVES OF DISEASE IN CHILDHOOD, 1991, 66 (04) : 462 - 466
12345